http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2019000573-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae10212794160b34478f0d05b6ab6fd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9af4d89807e0db8298692dffeabf875
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2019-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ca30fcefb9e2d1eceb8d86b353ee30b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3c87ce3e255f3cab8f2918517cb4c72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dcc4b13f8d25881dc462c1f9b4e3bbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06287351ad7a766de6541f1828cc9dbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1385e25ed420e165e06272b147f8c9e
publicationDate 2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2019000573-A1
titleOfInvention Compositions for tablets.
abstract THIS IS PROVIDED A TABLET THAT INCLUDES 2-METHYL-1 - [(4- [6- (TRIFLUOROMETIL) PIRIDIN-2-IL] -6 - {[2- (TRIFLUOROMETIL) PIRIDIN-4-IL] AMINO} - 1,3,5-TRIAZIN-2-IL) AMINO] PROPAN-2-OL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THIS.
priorityDate 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958

Total number of triples: 31.